Report : South America Cardiovascular Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device [Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others], Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others), and End User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers)
Hospitals Segment to Dominate South America Cardiovascular Devices market Forecast to 2028 during 2019–2028
According to a new market research study on the South America Cardiovascular Devices market Forecast to 2028 –– by device, application vertical and countries is expected to reach US$ 3,061.07 million by 2028 from US$ 2,054.15 million in 2021. The market is estimated to grow at a CAGR of 5.9%from 2021 to 2028. The report provides trends prevailing in the South America Cardiovascular Devices market along with the drivers and restraints pertaining to the market growth. Increasing prevalence of cardiovascular diseases is the major factor driving the growth of the South America Cardiovascular Devices market. However, issues associated with high cost of products and procedures the growth of South America Cardiovascular Devices market.
The South America Cardiovascular Devices market segmented into device, application, end user and country. Based on device the South America Cardiovascular Devices market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment is dominated South America Cardiovascular Devices market in 2020.Based on application the South America Cardiovascular Devices market segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease and others. The coronary heart disease segment South America Cardiovascular Devices market Dominated in 2020. Based on end user the South America Cardiovascular Devices market segmented into hospitals, ambulatory surgery centers and cardiac centers. The hospitals segment is dominated South America Cardiovascular Devices market in 2020.Based on country, The South America Cardiovascular Devices market segmented into Brazil, Argentina and RoSCAM. The Brazil is dominated the South America Cardiovascular Devices market in 2020.
Medtronic, Boston Scientific Corporation, Abbott, Jhonson and Jhonson Service Inc, General Electric Company,Koninlijke Philips N.V, Siemens Healthineers AG, BD,B.Bruna melsungen AG and Edwards Lifesciences Corporation are among the leading companies in South America Cardiovascular Devices market. For instance, Dec-2021 Boston Scientific Corporation had initiated the MODULAR ATP clinical trial to evaluate the safety, performance, and effectiveness of the mCRM Modular Therapy System. The mCRM System consists of two cardiac rhythm management (CRM) devices intended to work together to coordinate therapy: the EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System and the EMPOWER Modular Pacing System (MPS), which is designed to be the first leadless pacemaker capable of delivering both bradycardia pacing support and antitachycardia pacing (ATP). The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in dynamic market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: sales@businessmarketinsights.com